<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Zhou Y</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>CEUS LI-RADS and CT/MRI LI-RADS have been used in clinical practice for several years. However, there is a lack of evidence-based study to compare the proportion of hepatocellular carcinomas (HCCs) in each category and the distribution of HCCs of these two categorization systems.&lt;h4>Purpose&lt;/h4>The purpose of this study was to compare the proportion of HCCs between corresponding CEUS LI-RADS and CT/MRI LI-RADS categories and the distribution of HCCs and non-HCC malignancies in each category.&lt;h4>Methods&lt;/h4>We searched PubMed, Embase, and Cochrane Central databases from January 2014 to December 2021. The proportion of HCCs and non-HCC malignancies and the corresponding sensitivity, specificity, accuracy, diagnostic odds ratio (DOR), and area under the curve (AUC) of the L</pubmed_abstract><journal>Frontiers in oncology</journal><pagination>873913</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9001845</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Risk Stratification and Distribution of Hepatocellular Carcinomas in CEUS and CT/MRI LI-RADS: A Meta-Analysis.</pubmed_title><pmcid>PMC9001845</pmcid><pubmed_authors>Jing X</pubmed_authors><pubmed_authors>Zhao L</pubmed_authors><pubmed_authors>Qin Z</pubmed_authors><pubmed_authors>Wang F</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Ding J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Risk Stratification and Distribution of Hepatocellular Carcinomas in CEUS and CT/MRI LI-RADS: A Meta-Analysis.</name><description>&lt;h4>Background&lt;/h4>CEUS LI-RADS and CT/MRI LI-RADS have been used in clinical practice for several years. However, there is a lack of evidence-based study to compare the proportion of hepatocellular carcinomas (HCCs) in each category and the distribution of HCCs of these two categorization systems.&lt;h4>Purpose&lt;/h4>The purpose of this study was to compare the proportion of HCCs between corresponding CEUS LI-RADS and CT/MRI LI-RADS categories and the distribution of HCCs and non-HCC malignancies in each category.&lt;h4>Methods&lt;/h4>We searched PubMed, Embase, and Cochrane Central databases from January 2014 to December 2021. The proportion of HCCs and non-HCC malignancies and the corresponding sensitivity, specificity, accuracy, diagnostic odds ratio (DOR), and area under the curve (AUC) of the L</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-22T19:44:50.186Z</modification><creation>2025-04-06T02:52:41.575Z</creation></dates><accession>S-EPMC9001845</accession><cross_references><pubmed>35425706</pubmed><doi>10.3389/fonc.2022.873913</doi></cross_references></HashMap>